Sanofi (SNY) Inventory (2009 - 2025)

Sanofi has disclosed Inventory across 17 years of filings, most recently posting $11.9 billion for Q4 2025.

• Inventory for Q4 2025 came in at $11.9 billion, up 17.98% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.9 billion (up 17.98% YoY), and the FY2025 annual result was $11.9 billion, up 17.98% from the prior year.
• Inventory came in at $11.9 billion for Q4 2025 at Sanofi, up from $10.9 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $11.9 billion in Q4 2025 to a low of $9.1 billion in Q4 2022.
• The 5-year median for Inventory is $10.6 billion (2023), against an average of $10.6 billion.
• Across the five-year window, Inventory slipped 10.39% in 2022 and increased 17.98% in 2025, its largest moves.
• Sanofi's Inventory stood at $10.0 billion in 2021, then slipped by 8.31% to $9.1 billion in 2022, then climbed by 13.77% to $10.4 billion in 2023, then retreated by 3.1% to $10.1 billion in 2024, then increased by 17.98% to $11.9 billion in 2025.
• The last three Inventory figures came in at $11.9 billion (Q4 2025), $10.9 billion (Q2 2025), and $10.1 billion (Q4 2024), per Business Quant data.